A case of neonatal persistent hyperinsulinemichypoglycemia

Auteurs-es

  • Mauro Iannelli Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • Alessandra Li Pomi Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • Fabio Sippelli Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • A. Spagnolo Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • I. Rulli Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • Fortunato Lombrado Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina
  • Malgorzata Gabriela Wasniewska Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina
  • Tommaso Aversa Department of Human Pathology of Adulthood and Childhood, Unit of Pediatrics, University of Messina
  • Eloisa Gitto Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina

DOI :

https://doi.org/10.13129/1828-6550/APMB.110.1.2022.CCS4

Mots-clés :

hypoglycemia, congenital, hyperinsulinism, diazoxide

Résumé

Neonatal hypoglycemia (NH) is a common and important cause of morbidity in newborns. The most common cause of NH is congenital hyperinsulinism (CHI), a phenotypical and genotypical heterogeneous condition characterized by inappropriate insulin secretion. In our case a male, AGA, newborn from vaginal delivery at 37-week gestation, with no risk factors in maternal history, presented with asymptomatic hypoglycemia (30 mg/dL) at 30 minutes after birth. He was subsequently admitted to the NICU because of persistent hypoglycemia associated with symptoms development (peripheral tremors). Newborns can present with a wide variety of symptoms, including irritability, tremor, feeding impairment, coma, or be completely asymptomatic.

He was treated with continuous glucose infusions progressively increased to a rate of 12.7mg/kg/min. Because of persistent hypoglycemia (> 72h) and high i.v. glucose needs (>10 mg/kg/min) screening tests during fast-induced hypoglycemia were performed and isolated hyperinsulinism was detected. Oral medical therapy with diazoxide was started with benefit. Genetic testing was also performed to characterize CHI.

The diagnosis is usually based on clinical and biochemical findings. The mainstay of therapy is oral diazoxide administration. However, in cases refractory to medical therapy, 18F- DOPA-PET can be used to identify specific histological patterns which may need surgical intervention.  

Neonatal CHI-induced hypoglycemia should always be considered in the differential diagnosis of NH. Prompt diagnosis and genotypic characterization of CHI through clinical, biochemical, radiological, and genetic testing is fundamental for a proper therapeutic management of the condition and for prevention of neurological sequelae.

Références

1. James, C., Kapoor, R. R., Ismail, D., & Hussain, K. (2009). The genetic basis of congenital hyperinsulinism. Journal of medical genetics, 46(5), 289–299.doi:10.1136/jmg.2008.064337

2. Dillon P. A. (2013). Congenital hyperinsulinism. Current opinion in pediatrics, 25(3), 357–361.doi:10.1097/MOP.0b013e3283600ebb

3. Hussain, K., & Aynsley-Green, A. (2003). Hyperinsulinism in infancy: understanding the pathophysiology. The international journal of biochemistry & cell biology, 35(9), 1312–1317.doi:10.1016/s1357-2725(03)00103-1

4. Otonkoski, T., Näntö-Salonen, K., Seppänen, M., Veijola, R., Huopio, H., Hussain, K., Tapanainen, P., Eskola, O., Parkkola, R., Ekström, K., Guiot, Y., Rahier, J., Laakso, M., Rintala, R., Nuutila, P., & Minn, H. (2006). Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes, 55(1), 13–18.

5. Wang, W. Y., Sun, Y., Zhao, W. T., Wu, T., Wang, L., Yuan, T. M., & Yu, H. M. (2017). Congenital Hyperinsulinism in China: A Review of Chinese Literature Over the Past 15 Years. Journal of clinical research in pediatric endocrinology, 9(3), 194–201.doi:10.4274/jcrpe.3934

6. Senniappan, S., Shanti, B., James, C., & Hussain, K. (2012). Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. Journal of inherited metabolic disease, 35(4), 589–601.doi:10.1007/s10545-011-9441-2

7. Hussain, K., Blankenstein, O., De Lonlay, P., & Christesen, H. T. (2007). Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Archives of disease in childhood, 92(7), 568–570.doi:10.1136/adc.2006.115543

8. Gutgold, A., Gross, D. J., Glaser, B., & Szalat, A. (2017). Diagnosis of ABCC8 Congenital Hyperinsulinism of Infancy in a 20-Year-Old Man Evaluated for Factitious Hypoglycemia. The Journal of clinical endocrinology and metabolism, 102(2), 345–349.doi:10.1210/jc.2016-3254

9. Ferrara, C., Patel, P., Becker, S., Stanley, C. A., & Kelly, A. (2016). Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children. The Journal of pediatrics, 168, 212–219.doi:10.1016/j.jpeds.2015.09.045

10. Kapoor, R. R., James, C., & Hussain, K. (2009). Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nature clinical practice. Endocrinology & metabolism, 5(2), 101–112.doi:10.1038/ncpendmet1046

11. Lord, K., & De León, D. D. (2013). Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. International journal of pediatric endocrinology, 2013(1), 3.doi:10.1186/1687-9856-2013-3

12. Garg, P. K., Lokitz, S. J., Truong, L., Putegnat, B., Reynolds, C., Rodriguez, L., Nazih, R., Nedrelow, J., Guardia, M., Uffman, J. K., Garg, S., & Thornton, P. S. (2017). Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism. PloS one, 12(11), e0186340.doi:10.1371/journal.pone.0186340

.Hasbaoui, B. E., Elyajouri, A., Abilkassem, R., & Agadr, A. (2020). Congenital hyperinsulinsim: case report and review of literature. The Pan African medical journal, 35, 53.doi:10.11604/pamj.2020.35.53.16604

Téléchargements

Publié

2022-06-09

Numéro

Vol. 110 No. 1 (2022)

Rubrique

CLINICAL CASE SEMINAR

Licence

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).